Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Data on the transcriptional response to MESH1 knockdown and mammalian stringent response. | Data Brief | 2023 | 36761407 | PubTator, text mining | PubMed |
| Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment. | Transl Cancer Res | 2023 | 36760385 | PubTator, text mining | PubMed |
| ncRNA-mediated low expression of P2RY14 correlates with poor prognosis and tumor immune infiltration in ovarian carcinoma. | Ann Transl Med | 2023 | 36760244 | PubTator, text mining | PubMed |
| Multimodal single-cell analyses of peripheral blood mononuclear cells of COVID-19 patients in Japan. | Sci Rep | 2023 | 36732528 | PubTator, text mining | PubMed |
| Relationships of tumor differentiation and immune infiltration in gastric cancers revealed by single-cell RNA-seq analyses. | Cell Mol Life Sci | 2023 | 36729271 | PubTator, text mining | PubMed |
| The Legacy of Infectious Disease Exposure on the Genomic Diversity of Indigenous Southern Mexicans. | Genome Biol Evol | 2023 | 36726304 | PubTator, text mining | PubMed |
| Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins. | Cell Rep | 2023 | 36724073 | PubTator, text mining | PubMed |
| The role of HLA genotypes in understanding the pathogenesis of severe COVID-19. | Egypt J Med Hum Genet | 2023 | 36718139 | PubTator, text mining | PubMed |
| EpiMix: an integrative tool for epigenomic subtyping using DNA methylation. | bioRxiv | 2023 | 36711917 | PubTator, text mining | PubMed |
| Comparison between qPCR and RNA-seq reveals challenges of quantifying HLA expression. | Immunogenetics | 2023 | 36707444 | PubTator, text mining | PubMed |
| Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression. | Sci Adv | 2023 | 36706185 | PubTator, text mining | PubMed |
| A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report. | J Med Case Rep | 2023 | 36703182 | PubTator, text mining | PubMed |
| Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial. | Nat Med | 2023 | 36702949 | PubTator, text mining | PubMed |
| Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors. | J Endocr Soc | 2023 | 36694808 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing and deep tissue proteomics reveal distinct tumour microenvironment in stage-I and II cervical cancer. | J Exp Clin Cancer Res | 2023 | 36683048 | PubTator, text mining | PubMed |
| Spatial Profile of Tumor Microenvironment in PD-L1-Negative and PD-L1-Positive Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 36674951 | PubTator, text mining | PubMed |
| Multiomics Analysis Reveals Cuproptosis-Related Signature for Evaluating Prognosis and Immunotherapy Efficacy in Colorectal Cancer. | Cancers (Basel) | 2023 | 36672336 | PubTator, text mining | PubMed |
| Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment. | Cancers (Basel) | 2023 | 36672324 | PubTator, text mining | PubMed |
| Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants. | Cell Rep | 2023 | 36656713 | PubTator, text mining | PubMed |
| Clustering by antigen-presenting genes reveals immune landscapes and predicts response to checkpoint immunotherapy. | Sci Rep | 2023 | 36653470 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=27